Physician profile
Marlene Wang
NPI 1578918272
$2,260.57
in general payments reported to CMS, 2019-2025
14 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $167 · 2021: $823 · 2022: $398 · 2023: $286 · 2024: $379 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,113.17 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $358.35 | 2022-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $234.40 | 2023-2025 | Lumigan, Alphagan P, Vuity |
| Eyepoint US, INC. | $112.27 | 2022 | |
| Astellas Pharma US INC | $84.22 | 2024-2025 | Izervay |
| Alimera Sciences, INC. | $70.32 | 2022-2023 | Iluvien |
| Genentech USA, INC. | $69.58 | 2023-2024 | Vabysmo |
| Sight Sciences, INC. | $51.97 | 2023 | Omni Surgical System, Sion Surgical Instrument |
| Coherus Oncology, INC. | $47.36 | 2024 | |
| Sandoz INC. | $42.05 | 2024 | Cimerli |
| Bausch & Lomb Americas INC. | $21.65 | 2023 | Surgical Misc |
| Apellis Pharmaceuticals, INC. | $19.71 | 2023 | Syfovre |
| Ani Pharmaceuticals, INC. | $18.98 | 2025 | Yutiq |
| Genentech, INC. | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.